68 related articles for article (PubMed ID: 11101799)
1. Viral vectors do the DNA shuffle.
Miyanohara A; Friedmann T
Nat Biotechnol; 2000 Dec; 18(12):1244-5. PubMed ID: 11101799
[No Abstract] [Full Text] [Related]
2. Breeding of retroviruses by DNA shuffling for improved stability and processing yields.
Powell SK; Kaloss MA; Pinkstaff A; McKee R; Burimski I; Pensiero M; Otto E; Stemmer WP; Soong NW
Nat Biotechnol; 2000 Dec; 18(12):1279-82. PubMed ID: 11101807
[TBL] [Abstract][Full Text] [Related]
3. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
4. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
5. [Prokaryotic expression and purification of moloney murine leukemia virus reverse transcriptase and verification of the activity].
Wang X; Ma X; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):903-6. PubMed ID: 18724716
[TBL] [Abstract][Full Text] [Related]
6. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
7. Replicative retroviral vectors for cancer gene therapy.
Solly SK; Trajcevski S; Frisén C; Holzer GW; Nelson E; Clerc B; Abordo-Adesida E; Castro M; Lowenstein P; Klatzmann D
Cancer Gene Ther; 2003 Jan; 10(1):30-9. PubMed ID: 12489026
[TBL] [Abstract][Full Text] [Related]
8. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
10. Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.
Dubensky TW; Sauter SL
Methods Mol Med; 2003; 76():309-30. PubMed ID: 12526171
[No Abstract] [Full Text] [Related]
11. Step taken toward improved vectors for gene transfer.
Barinaga M
Science; 1994 Nov; 266(5189):1326. PubMed ID: 7973723
[No Abstract] [Full Text] [Related]
12. Increase in infectivity of targeted Moloney murine leukemia virus-based gene-delivery vectors through lowering the threshold for fusion.
Viejo-Borbolla A; Thomas P; Blair ED; Schulz TF
J Gen Virol; 2005 Sep; 86(Pt 9):2469-2480. PubMed ID: 16099905
[TBL] [Abstract][Full Text] [Related]
13. Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
Fraisier C; Arnarson H; Barbezange C; Andrésdŏttir V; Carrozza ML; De Andrés D; Tolari F; Rosati S; Luján L; Pépin M; Amorena B; Harkiss G; Blacklaws B; Suzan-Monti M
J Virol Methods; 2007 Dec; 146(1-2):363-7. PubMed ID: 17675253
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
15. Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein.
Kuznetsov YG; Low A; Fan H; McPherson A
Virology; 2004 Jun; 323(2):189-96. PubMed ID: 15193915
[TBL] [Abstract][Full Text] [Related]
16. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
[TBL] [Abstract][Full Text] [Related]
18. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication.
Pfeiffer JK; Telesnitsky A
J Virol; 2001 Dec; 75(23):11263-74. PubMed ID: 11689606
[TBL] [Abstract][Full Text] [Related]
19. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
20. Transient production of retroviral- and lentiviral-based vectors for the transduction of Mammalian cells.
Tonini T; Claudio PP; Giordano A; Romano G
Methods Mol Biol; 2004; 285():141-8. PubMed ID: 15269408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
